About 444 results
Center for Biosimilars®
FDA Approves Semglee Insulin Glargine as First Interchangeable …
FDA Approves First Subcutaneous Infliximab Product - Center for …
Amgen Executive Weighs the Challenges for Interchangeable …
FDA Approves Pfizer's Trastuzumab Biosimilar, Trazimera
Switching Among Multiple Infliximab Biosimilars Does Not Cause ...
FDA Releases Guidance on Biologic, Biosimilar, and …
FDA Finalizes Guidance on Interchangeable Biosimilars
In the Effort to Develop Global Comparator Products, Biosimilars …
Understanding the Risks, Opportunities, and Prospects of …